-
1
-
-
0024421391
-
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
-
Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989;2:1004-6. (Pubitemid 19257915)
-
(1989)
Lancet
, vol.2
, Issue.8670
, pp. 1004-1006
-
-
Bruix, J.1
Calvet, X.2
Costa, J.3
Ventura, M.4
Bruguera, M.5
Castillo, R.6
Barrera, J.M.7
Ercilla, G.8
Sanchez-Tapias, J.M.9
Vall, M.10
Bru, C.11
Rodes, J.12
-
2
-
-
0024450697
-
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
-
Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989;2:1006-8. (Pubitemid 19257916)
-
(1989)
Lancet
, vol.2
, Issue.8670
, pp. 1006-1008
-
-
Colombo, M.1
Choo, Q.L.2
Del Ninno, E.3
Dioguardi, N.4
Kuo, G.5
Donato, M.F.6
Tommasini, M.A.7
Houghton, M.8
-
3
-
-
0025086939
-
Hepatitis C-associated hepatocellular carcinoma
-
Hasan F, Jeffers LJ, De Medina M, Reddy KR, Parker T, Schiff ER, Houghton M, Choo QL, Kuo G. Hepatitis C-associated hepatocellular carcinoma. Hepatology. 1990;12:589-91. (Pubitemid 20382027)
-
(1990)
Hepatology
, vol.12
, Issue.3
, pp. 589-591
-
-
Hasan, F.1
Jeffers, L.J.2
De Medina, M.3
Reddy, K.R.4
Parker, T.5
Schiff, E.R.6
Houghton, M.7
Choo, Q.8
Kuo, G.9
-
4
-
-
0027229211
-
A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
-
DOI 10.1016/0270-9139(93)90505-H
-
Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, Kawanishi M. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993;18:47-53. (Pubitemid 23193616)
-
(1993)
Hepatology
, vol.18
, Issue.1
, pp. 47-53
-
-
Ikeda, K.1
Saitoh, S.2
Koida, I.3
Arase, Y.4
Tsubota, A.5
Chayama, K.6
Kumada, H.7
Kawanishi, M.8
-
5
-
-
0027243462
-
Risk factors for hepatocellular carcinoma among patients with chronic liver disease
-
DOI 10.1056/NEJM199306243282501
-
Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328:1797-801. (Pubitemid 23174709)
-
(1993)
New England Journal of Medicine
, vol.328
, Issue.25
, pp. 1797-1801
-
-
Tsukuma, H.1
Hiyama, T.2
Tanaka, S.3
Nakao, M.4
Yabuuchi, T.5
Kitamura, T.6
Nakanishi, K.7
Fujimoto, I.8
Inoue, A.9
Yamazaki, H.10
Kawashima, T.11
-
6
-
-
7044272630
-
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
-
DOI 10.1053/j.gastro.2004.09.014, PII S0016508504015938
-
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35-50. (Pubitemid 39423368)
-
(2004)
Gastroenterology
, vol.127
, Issue.SUPPL.
-
-
Fattovich, G.1
Stroffolini, T.2
Zagni, I.3
Donato, F.4
-
7
-
-
34248355202
-
Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: A prospective study
-
Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med. 2007;146:649-56. (Pubitemid 351650520)
-
(2007)
Annals of Internal Medicine
, vol.146
, Issue.9
, pp. 649-656
-
-
Ikeda, K.1
Marusawa, H.2
Osaki, Y.3
Nakamura, T.4
Kitajima, N.5
Yamashita, Y.6
Kudo, M.7
Sato, T.8
Chiba, T.9
-
8
-
-
7044272621
-
Pathogenesis of hepatitis C-associated hepatocellular carcinoma
-
DOI 10.1053/j.gastro.2004.09.017, PII S0016508504015963
-
Liang TJ, Heller T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology. 2004;127:S62-71. (Pubitemid 39423371)
-
(2004)
Gastroenterology
, vol.127
, Issue.SUPPL.
-
-
Liang, T.J.1
Heller, T.2
-
9
-
-
0033520109
-
Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan
-
Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Inoue O, Yano M, Tanaka M, Fujiyama S, Nishiguchi S, Kuroki T, Imazeki F, Yokosuka O, Kinoyama S, Yamada G, Omata M. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of hepatocarcinogenesis by interferon therapy. Ann Intern Med. 1999;131:174-81. (Pubitemid 29364999)
-
(1999)
Annals of Internal Medicine
, vol.131
, Issue.3
, pp. 174-181
-
-
Yoshida, H.1
Shiratori, Y.2
Moriyama, M.3
Arakawa, Y.4
Ide, T.5
Sata, M.6
Inoue, O.7
Yano, M.8
Tanaka, M.9
Fujiyama, S.10
Nishiguchi, S.11
Kuroki, T.12
Imazeki, F.13
Yokosuka, O.14
Kinoyama, S.15
Yamada, G.16
Omata, M.17
-
10
-
-
7044263003
-
Prevention of hepatitis C virus-related hepatocellular carcinoma
-
DOI 10.1053/j.gastro.2004.09.044, PII S0016508504016233
-
Heathcote EJ. Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology. 2004;127:S294-302. (Pubitemid 39423399)
-
(2004)
Gastroenterology
, vol.127
, Issue.SUPPL.
-
-
Heathcote, E.J.1
-
11
-
-
59849093175
-
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
-
Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009; 136:138-48.
-
(2009)
Gastroenterology
, vol.136
, pp. 138-148
-
-
Lok, A.S.1
Seeff, L.B.2
Morgan, T.R.3
Di Bisceglie, A.M.4
Sterling, R.K.5
Curto, T.M.6
Everson, G.T.7
Lindsay, K.L.8
Lee, W.M.9
Bonkovsky, H.L.10
Dienstag, J.L.11
Ghany, M.G.12
Morishima, C.13
Goodman, Z.D.14
-
12
-
-
0032560376
-
Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study
-
International Interferon-alpha Hepatocellular Carcinoma Study Group
-
Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group. Lancet. 1998;351:1535-9.
-
(1998)
Lancet
, vol.351
, pp. 1535-1539
-
-
-
13
-
-
0035061788
-
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: An evidence-based approach
-
DOI 10.1016/S0168-8278(01)00005-8, PII S0168827801000058
-
Camma C, Giunta M, Andreone P, Craxi A. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol. 2001;34:593-602. (Pubitemid 32328518)
-
(2001)
Journal of Hepatology
, vol.34
, Issue.4
, pp. 593-602
-
-
Camma, C.1
Giunta, M.2
Andreone, P.3
Crax, A.4
-
14
-
-
57349116772
-
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon
-
Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008;359:2429-41.
-
(2008)
N Engl J Med.
, vol.359
, pp. 2429-2441
-
-
Di Bisceglie, A.M.1
Shiffman, M.L.2
Everson, G.T.3
Lindsay, K.L.4
Everhart, J.E.5
Wright, E.C.6
Lee, W.M.7
Lok, A.S.8
Bonkovsky, H.L.9
Morgan, T.R.10
Ghany, M.G.11
Morishima, C.12
Snow, K.K.13
Dienstag, J.L.14
-
15
-
-
0030744373
-
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C
-
DOI 10.1016/S0168-8278(97)80302-9
-
Fattovich G, Giustina G, Degos F, Diodati G, Tremolada F, Nevens F, Almasio P, Solinas A, Brouwer JT, Thomas H, Realdi G, Corrocher R, Schalm SW. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma, decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol. 1997;27:201-5. (Pubitemid 27357077)
-
(1997)
Journal of Hepatology
, vol.27
, Issue.1
, pp. 201-205
-
-
Fattovich, G.1
Giustina, G.2
Degos, F.3
Diodati, G.4
Tremolada, F.5
Nevens, F.6
Almasio, P.7
Solinas, A.8
Brouwer, J.T.9
Thomas, H.10
Realdi, G.11
Corrocher, R.12
Schalm, S.W.13
-
16
-
-
0036016514
-
Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy
-
Hayashi K, Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Toyoda H, Shimizu H, Honda T. Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy. Hepatogastroenterology. 2002;49:508-12. (Pubitemid 34606584)
-
(2002)
Hepato-Gastroenterology
, vol.49
, Issue.44
, pp. 508-512
-
-
Hayashi, K.1
Kumada, T.2
Nakano, S.3
Takeda, I.4
Kiriyama, S.5
Sone, Y.6
Toyoda, H.7
Shimizu, H.8
Honda, T.9
-
17
-
-
79952316752
-
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C
-
Lok AS, Everhart JE, Wright EC, Di Bisceglie AM, Kim HY, Sterling RK, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Morgan TR. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology. 2011;140:840-9.
-
(2011)
Gastroenterology
, vol.140
, pp. 840-849
-
-
Lok, A.S.1
Everhart, J.E.2
Wright, E.C.3
Di Bisceglie, A.M.4
Kim, H.Y.5
Sterling, R.K.6
Everson, G.T.7
Lindsay, K.L.8
Lee, W.M.9
Bonkovsky, H.L.10
Dienstag, J.L.11
Ghany, M.G.12
Morishima, C.13
Morgan, T.R.14
-
18
-
-
0028876371
-
Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
-
Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995;346:1051-5.
-
(1995)
Lancet
, vol.346
, pp. 1051-1055
-
-
Nishiguchi, S.1
Kuroki, T.2
Nakatani, S.3
Morimoto, H.4
Takeda, T.5
Nakajima, S.6
Shiomi, S.7
Seki, S.8
Kobayashi, K.9
Otani, S.10
-
19
-
-
0032996855
-
Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: A retrospective study in 1148 patients
-
DOI 10.1016/S0168-8278(99)80196-2
-
Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M, Nishioji K, Murakami Y, Kashima K. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group. J Hepatol. 1999;30:653-9. (Pubitemid 29151907)
-
(1999)
Journal of Hepatology
, vol.30
, Issue.4
, pp. 653-659
-
-
Okanoue, T.1
Itoh, Y.2
Minami, M.3
Sakamoto, S.4
Yasui, K.5
Sakamoto, M.6
Nishioji, K.7
Murakami, Y.8
-
20
-
-
0029124120
-
Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: A prospective study
-
Izuno K, Fujiyama S, Yamasaki K, Sato M, Sato T. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study. Hepatogastroenterology. 1995;42:387-93.
-
(1995)
HepatoGastroenterology
, vol.42
, pp. 387-393
-
-
Izuno, K.1
Fujiyama, S.2
Yamasaki, K.3
Sato, M.4
Sato, T.5
-
21
-
-
0035056663
-
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status
-
DOI 10.1016/S0168-8278(00)00053-2, PII S0168827800000532
-
Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, De Notariis S, Roda E, Bernardi M. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol. 2001;34:570-5. (Pubitemid 32328514)
-
(2001)
Journal of Hepatology
, vol.34
, Issue.4
, pp. 570-575
-
-
Trevisani, F.1
D'Intino, P.E.2
Morselli-Labate, A.M.3
Mazzella, G.4
Accogli, E.5
Caraceni, P.6
Domenicali, M.7
De Notariis, S.8
Roda, E.9
Bernardi, M.10
-
22
-
-
0029839931
-
Efficacy of a surveillance program for early detection of hepatocellular carcinoma
-
DOI 10.1002/(SICI)1097-0142(19960901)78:5<977::AID-CNCR6>3.0.CO;2-9
-
Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer. 1996;78:977-85. (Pubitemid 26284861)
-
(1996)
Cancer
, vol.78
, Issue.5
, pp. 977-985
-
-
Zoli, M.1
Magalotti, D.2
Blanchi, G.3
Gueli, C.4
Marchesini, G.5
Pisi, E.6
-
23
-
-
0018092458
-
α-Fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not include AFP synthesis
-
Alpert E, Feller ER. Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology. 1978;74:856-8. (Pubitemid 8332340)
-
(1978)
Gastroenterology
, vol.74
, Issue.5
, pp. 856-858
-
-
Alpert, E.1
Feller, E.R.2
-
25
-
-
0015495041
-
Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease
-
Ruoslahti E, Seppala M. Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease. Lancet. 1972;2: 278-9.
-
(1972)
Lancet.
, vol.2
, pp. 278-279
-
-
Ruoslahti, E.1
Seppala, M.2
-
26
-
-
0041667787
-
Lens culinaris agglutinin-A-reactive alpha-fetoprotein ad a marker for liver atrophy in fulminant hepatic failure
-
DOI 10.1016/S1386-6346(03)00013-5
-
Sakurai T, Marusawa H, Satomura S, Nabeshima M, Uemoto S, Tanaka K, Chiba T. Lens culinaris agglutinin-A-reactive alphafetoprotein as a marker for liver atrophy in fulminant hepatic failure. Hepatol Res. 2003;26:98-105. (Pubitemid 36927179)
-
(2003)
Hepatology Research
, vol.26
, Issue.2
, pp. 98-105
-
-
Sakurai, T.1
Marusawa, H.2
Satomura, S.3
Nabeshima, M.4
Uemoto, S.5
Tanaka, K.6
Chiba, T.7
-
27
-
-
0025696558
-
Alpha-fetoprotein: reevaluation in hepatology
-
Taketa K. Alpha-fetoprotein: reevaluation in hepatology. Hepatology. 1990;12:1420-32.
-
(1990)
Hepatology.
, vol.12
, pp. 1420-1432
-
-
Taketa, K.1
-
28
-
-
23444432469
-
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
-
DOI 10.1016/j.jhep.2005.03.019, PII S0168827805003090
-
Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR. Serum alphafetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol. 2005;43:434-41. (Pubitemid 41111424)
-
(2005)
Journal of Hepatology
, vol.43
, Issue.3
, pp. 434-441
-
-
Di Bisceglie, A.M.1
Sterling, R.K.2
Chung, R.T.3
Everhart, J.E.4
Dienstag, J.L.5
Bonkovsky, H.L.6
Wright, E.C.7
Everson, G.T.8
Lindsay, K.L.9
Lok, A.S.F.10
Lee, W.M.11
Morgan, T.R.12
Ghany, M.G.13
Gretch, D.R.14
-
29
-
-
78651511517
-
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
-
Tateyama M, Yatsuhashi H, Taura N, Motoyoshi Y, Nagaoka S, Yanagi K, Abiru S, Yano K, Komori A, Migita K, Nakamura M, Nagahama H, Sasaki Y, Miyakawa Y, Ishibashi H. Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol. 2011;46:92-100.
-
(2011)
J Gastroenterol
, vol.46
, pp. 92-100
-
-
Tateyama, M.1
Yatsuhashi, H.2
Taura, N.3
Motoyoshi, Y.4
Nagaoka, S.5
Yanagi, K.6
Abiru, S.7
Yano, K.8
Komori, A.9
Migita, K.10
Nakamura, M.11
Nagahama, H.12
Sasaki, Y.13
Miyakawa, Y.14
Ishibashi, H.15
-
30
-
-
33645848470
-
A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP
-
Murashima S, Tanaka M, Haramaki M, Yutani S, Nakashima Y, Harada K, Ide T, Kumashiro R, Sata M. A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP. Dig Dis Sci. 2006;51: 808-12.
-
(2006)
Dig Dis Sci.
, vol.51
, pp. 808-812
-
-
Murashima, S.1
Tanaka, M.2
Haramaki, M.3
Yutani, S.4
Nakashima, Y.5
Harada, K.6
Ide, T.7
Kumashiro, R.8
Sata, M.9
-
31
-
-
70350221879
-
Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C
-
Tamura Y, Yamagiwa S, Aoki Y, Kurita S, Suda T, Ohkoshi S, Nomoto M, Aoyagi Y. Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C. Dig Dis Sci. 2009;54:2530-7.
-
(2009)
Dig Dis Sci.
, vol.54
, pp. 2530-2537
-
-
Tamura, Y.1
Yamagiwa, S.2
Aoki, Y.3
Kurita, S.4
Suda, T.5
Ohkoshi, S.6
Nomoto, M.7
Aoyagi, Y.8
-
32
-
-
34347348057
-
Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C
-
DOI 10.1002/jmv.20866
-
Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kumada H. Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C. J Med Virol. 2007;79: 1095-102. (Pubitemid 47015408)
-
(2007)
Journal of Medical Virology
, vol.79
, Issue.8
, pp. 1095-1102
-
-
Arase, Y.1
Ikeda, K.2
Suzuki, F.3
Suzuki, Y.4
Kobayashi, M.5
Akuta, N.6
Hosaka, T.7
Sezaki, H.8
Yatsuji, H.9
Kawamura, Y.10
Kobayashi, M.11
Kumada, H.12
-
33
-
-
77955739982
-
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection
-
Asahina Y, Tsuchiya K, Tamaki N, Hirayama I, Tanaka T, Sato M, Yasui Y, Hosokawa T, Ueda K, Kuzuya T, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Enomoto N, Izumi N. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology. 2010;52:518-27.
-
(2010)
Hepatology
, vol.52
, pp. 518-527
-
-
Asahina, Y.1
Tsuchiya, K.2
Tamaki, N.3
Hirayama, I.4
Tanaka, T.5
Sato, M.6
Yasui, Y.7
Hosokawa, T.8
Ueda, K.9
Kuzuya, T.10
Nakanishi, H.11
Itakura, J.12
Takahashi, Y.13
Kurosaki, M.14
Enomoto, N.15
Izumi, N.16
-
34
-
-
0031059949
-
New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a
-
Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JY. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997;35:201-7. (Pubitemid 26422655)
-
(1997)
Journal of Clinical Microbiology
, vol.35
, Issue.1
, pp. 201-207
-
-
Ohno, T.1
Mizokami, M.2
Wu, R.-R.3
Saleh, M.G.4
Ohba, K.-I.5
Orito, E.6
Mukaide, M.7
Williams, R.8
Lau, J.Y.N.9
-
35
-
-
61749098966
-
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels
-
Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Atsumi H, Takagi M, Nakano S, Arakawa T, Fujimori M. Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels. J Hepatol. 2009;50:729-35.
-
(2009)
J Hepatol
, vol.50
, pp. 729-735
-
-
Kumada, T.1
Toyoda, H.2
Kiriyama, S.3
Sone, Y.4
Tanikawa, M.5
Hisanaga, Y.6
Kanamori, A.7
Atsumi, H.8
Takagi, M.9
Nakano, S.10
Arakawa, T.11
Fujimori, M.12
-
36
-
-
34548247217
-
Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection
-
DOI 10.1002/jmv.20925
-
Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kumada H. Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection. J Med Virol. 2007;79:1485-90. (Pubitemid 47328737)
-
(2007)
Journal of Medical Virology
, vol.79
, Issue.10
, pp. 1485-1490
-
-
Arase, Y.1
Ikeda, K.2
Suzuki, F.3
Suzuki, Y.4
Kobayashi, M.5
Akuta, N.6
Hosaka, T.7
Sezaki, H.8
Yatsuji, H.9
Kawamura, Y.10
Kobayashi, M.11
Kumada, H.12
-
37
-
-
17344369924
-
Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
-
DOI 10.1002/hep.510270529
-
Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, Urushihara A, Kiyosawa K, Okuda M, Hino K, Okita K. Risk factors for hepatocellular carcinoma, its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology. 1998;27:1394-402. (Pubitemid 28228735)
-
(1998)
Hepatology
, vol.27
, Issue.5
, pp. 1394-1402
-
-
Kasahara, A.1
Hayashi, N.2
Mochizuki, K.3
Takayanagi, M.4
Yoshioka, K.5
Kakumu, S.6
Iijima, A.7
Urushihara, A.8
Kiyosawa, K.9
Okuda, M.10
Hino, K.11
Okita, K.12
-
38
-
-
65449140955
-
Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
-
Kurokawa M, Hiramatsu N, Oze T, Mochizuki K, Yakushijin T, Kurashige N, Inoue Y, Igura T, Imanaka K, Yamada A, Oshita M, Hagiwara H, Mita E, Ito T, Inui Y, Hijioka T, Yoshihara H, Inoue A, Imai Y, Kato M, Kiso S, Kanto T, Takehara T, Kasahara A, Hayashi N. Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis. Hepatol Res. 2009;39:432-8.
-
(2009)
Hepatol Res.
, vol.39
, pp. 432-438
-
-
Kurokawa, M.1
Hiramatsu, N.2
Oze, T.3
Mochizuki, K.4
Yakushijin, T.5
Kurashige, N.6
Inoue, Y.7
Igura, T.8
Imanaka, K.9
Yamada, A.10
Oshita, M.11
Hagiwara, H.12
Mita, E.13
Ito, T.14
Inui, Y.15
Hijioka, T.16
Yoshihara, H.17
Inoue, A.18
Imai, Y.19
Kato, M.20
Kiso, S.21
Kanto, T.22
Takehara, T.23
Kasahara, A.24
Hayashi, N.25
more..
-
39
-
-
0142061476
-
Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesis
-
Suzuki K, Ohkoshi S, Yano M, Ichida T, Takimoto M, Naitoh A, Mori S, Hata K, Igarashi K, Hara H, Ohta H, Soga K, Watanabe T, Kamimura T, Aoyagi Y. Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesis. Liver Int. 2003;23:143-7. (Pubitemid 37265786)
-
(2003)
Liver International
, vol.23
, Issue.3
, pp. 143-147
-
-
Suzuki, K.1
Ohkoshi, S.2
Yano, M.3
Ichida, T.4
Takimoto, M.5
Naitoh, A.6
Mori, S.7
Hara, K.8
Igarashi, K.9
Hara, H.10
Ohta, H.11
Soga, K.12
Watanabe, T.13
Kamimura, T.14
Aoyagi, Y.15
-
40
-
-
77956135578
-
Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
-
Kurosaki M, Hosokawa T, Matsunaga K, Hirayama I, Tanaka T, Sato M, Yasui Y, Tamaki N, Ueda K, Tsuchiya K, Kuzuya T, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Enomoto N, Izumi N. Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy. Hepatol Res. 2010;40:870-7.
-
(2010)
Hepatol Res.
, vol.40
, pp. 870-877
-
-
Kurosaki, M.1
Hosokawa, T.2
Matsunaga, K.3
Hirayama, I.4
Tanaka, T.5
Sato, M.6
Yasui, Y.7
Tamaki, N.8
Ueda, K.9
Tsuchiya, K.10
Kuzuya, T.11
Nakanishi, H.12
Itakura, J.13
Takahashi, Y.14
Asahina, Y.15
Enomoto, N.16
Izumi, N.17
-
41
-
-
79960268165
-
Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C
-
Takahashi H, Mizuta T, Eguchi Y, Kawaguchi Y, Kuwashiro T, Oeda S, Isoda H, Oza N, Iwane S, Izumi K, Anzai K, Ozaki I, Fujimoto K. Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C. J Gastroenterol. 2011;46:790-8.
-
(2011)
J Gastroenterol
, vol.46
, pp. 790-798
-
-
Takahashi, H.1
Mizuta, T.2
Eguchi, Y.3
Kawaguchi, Y.4
Kuwashiro, T.5
Oeda, S.6
Isoda, H.7
Oza, N.8
Iwane, S.9
Izumi, K.10
Anzai, K.11
Ozaki, I.12
Fujimoto, K.13
-
42
-
-
17944377722
-
Long-term follow-up of chronic hepatitis c in patients diagnosed at a tertiary-care center
-
DOI 10.1016/S0168-8278(01)00088-5, PII S0168827801000885
-
Forns X, Ampurdanes S, Sanchez-Tapias JM, Guilera M, Sans M, Sanchez-Fueyo A, Quinto L, Joya P, Bruguera M, Rodes J. Longterm follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center. J Hepatol. 2001;35:265-71. (Pubitemid 32803483)
-
(2001)
Journal of Hepatology
, vol.35
, Issue.2
, pp. 265-271
-
-
Forns, X.1
Ampurdanes, S.2
Sanchez-Tapias, J.M.3
Guilera, M.4
Sans, M.5
Sanchez-Fueyo, A.6
Quinto, L.7
Joya, P.8
Bruguera, M.9
Rodes, J.10
|